GERON CORP
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. : Other Information
Trading Arrangements
During the quarterly period covered by this report, the following directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement" (as such terms are defined in Item 408 of Regulation S-K) as set forth in the table below.
| Character of Trading Arrangement | ||||||
|---|---|---|---|---|---|---|
| Name and Title · Action Taken · Date of Action · Rule 10b5-1* · Non-Rule 10b5-1** · Nature of Trading Arrangement · Aggregate Number of Securities · Duration of Trading Arrangement | ||||||
| John A. Scarlett, M.D.,Former Chairman of the Board, President and Chief Executive Officer (until March 10, 2025) | Terminated | February 27, 2025 | X | Sale | 1,374,298 1 | July 12, 2024−July 11, 2025, or such earlier date on which all shares under the plan are sold. |
| Susan Molineaux, Ph.D.Director | Adopted | March 14, 2025 | X | Sale | 656,000 2 | March 14, 2025 −March 13, 2026, or such earlier date on which all shares under the plan are sold. |
| *Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. | ||||||
| **"Non-Rule 10b5-1 trading arrangement" as defined in Item 408(c) of Regulation S-K under the Exchange Act. | ||||||
1 Consists of 1,374,298 shares subject to stock options previously granted by Geron to Dr. Scarlett.
2 Consists of 656,000 shares subject to stock options previously granted by Geron to Dr. Molineaux.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.